
    
      The goal of this study is to demonstrate the clinical improvement and safety in patients
      treated with MONOVISC for shoulder osteoarthritis. Specifically, this study will provide
      confirmation to the effectiveness and safety of MONOVISC at relieving shoulder joint pain to
      6 months post-treatment.
    
  